Latest Pharmaceutical News
GVK Biosciences Establishes New Clinical Pharmacology Unit In Ahmedabad
GVK Biosciences (GVK BIO), an India-based contract research organisation, has opened a new clinical pharmacology unit (CPU) in Ahmedabad, India. The Ahmedabad CPU, which will conduct a variety of studies in healthy volunteers, adds 110 beds to GVK’s existing capacity of 144 beds.
Published: 17-Mar-2010
Tekmira Pharma, Pfizer Enter Into New Research Collaboration
Tekmira Pharmaceuticals (Tekmira), a developer of RNA interference (RNAi) therapeutics, has initiated a new research collaboration with Pfizer.
Published: 16-Mar-2010
West Coast Clinical Trials Inaugurates Second Facility In Costa Mesa, California
West Coast Clinical Trials, a private minority-owned independent Phase I-IV clinical research organisation located in Southern California, has opened a second facility in Costa Mesa, California.
Published: 15-Mar-2010
Vernalis Achieves Milestone Under Novartis Collaboration
Vernalis, a development stage pharma company with expertise both in de novo fragment and structure-based drug discovery and pre-clinical and clinical development, has achieved a milestone under collaboration with Novartis on the oncology target Hsp90.
Published: 15-Mar-2010
Ipsen, Rhythm Sign License Agreement For Programs In Metabolic Disorders
Ipsen, a global biotechnology specialty care group and Rhythm Pharmaceuticals (Rhythm), a biotechnology company developing peptide therapeutics for metabolic diseases, have concluded a license agreement for Ipsen’s proprietary peptide therapeutics targeting obesity, metabolic diseases and gastrointestinal disorders.
Published: 12-Mar-2010
Swedish Orphan Biovitrum, Amgen Ink Agreement For Additional Kineret Drug Campaign
Swedish Orphan Biovitrum has signed an agreement with Amgen to run an additional Kineret bulk drug campaign. Further, the company will pay to acquire previously agreed future sales milestones for Kepivance and Kineret.
Published: 11-Mar-2010
Laxai Pharma Acquires Assets Of OSR Solutions
Laxai Pharma has completed its first acquisition in the clinical research services space by purchasing all of the assets of OSR Solutions (OSR), a New Jersey based contract research organization (CRO).
Published: 11-Mar-2010
Human Genome Sciences Collaborates With BioInvent
Human Genome Sciences and BioInvent International have entered into a collaboration to discover, develop and commercialise therapeutic monoclonal antibodies that specifically target antigens discovered by HGS.
Published: 11-Mar-2010
AstraZeneca Eyes Bigger Generic Drug Pie In Emerging Markets
AstraZeneca has entered into a generic drug partnership with India-based Torrent Pharma, to brand and market 18 of the Indian drugmaker medicines in 9 emerging economies where it already has a strong commercial footprint.
Published: 11-Mar-2010
Cellzome Partners GSK For Inflammatory Disease Drug Discovery
Cellzome has formed a second strategic alliance with GlaxoSmithKline (GSK) to work on drug discovery for inflammatory disease, using the former's proteomics technology in epigenetics.
Published: 10-Mar-2010
